Please enable JavaScript.
Coggle requires JavaScript to display documents.
Biotechnology - Coggle Diagram
Biotechnology
AMR
way forward
Rational use required -use available antibiotics carefully so as to ensure efficiency for as long as possible
-
all word countries must develop their respective national action plan in alignment with the WHO above plan
One health approach
multi-sectoral, multi- disciplinary and multi-institutional response to public health problems,
-
mix of incentives and sanctions - i.e to both ensure access to antimicrobial to those in need and regulating its use at the same time (Sanction)
-
-
-
-
-
intro
-
antimicrobials - antibiotics, antivirals, antifungals - medicines to prevent and treat infections in humans, animals and plants
-
-
dikkat ki baat yeh hai ki -- no new classes of antibiotics developed in the last 3 decades - kyu? - inadequate incentives for their dev ,, production, R&D
-
-
cons
-
impact on health
-
-
-
-
surgical procedures, cancer chemo - will face risk from untreatable infections
-
and this scenario will be worst in low and middle income countries of Asia and Africa because already their health systems cannot bear the risk posed by untreatable infectious diseases and now when even treatable infectious diseases donot respond to drug -- burden on health system would increase exponentially
-
measures
international
One Health Global Leaders Group on AMR - by FAO, WHO and World Org for Animal Health
-
DNA Technology(Use and Application) Regulation Bill, 2019
-
-
-